Winczyk K, Kunert Radek J, Gruszka A, Radek M, Ławnicka H, Pawlikowski M. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro. Neuro Endocrinol Lett. 2009;30:107-10 pubmed
..Our data suggest that rosiglitazone may be useful in the treatment of non-functioning pituitary adenomas, but its efficacy in Cushing's disease and acromegaly requires further study. ..